DISC1 Mouse Models


Model

Approach

Function

Construct

Expression pattern

Gross anatomy

Cellular abnormalities

Behavior

Significance

Kamiya

In utero E14.5

KD function of endogenous Disc1

Disc1 RNAi or express

C-terminally truncated DISC1

Pyramidal cortical neurons

n/d

P2: Inhibition of neuronal migration.

P14: Shorter, misoriented dendrites

n/d

KD of Disc1 either with RNAi or with mDISC1 leads to abnormal development of the cortex

Duan

Oncoretrovirus injected into the adult dentate gyrus

KD endogenous Disc1

Disc1 RNAi

Hippocampus

n/d

Soma hypertrophy, multiple primary dendrites, overextended migration, and accelerated synaptogenesis

n/d

DISC1 is involved in embryonic and adult neuronal migration

Mao

In utero E13, BrdU 2 h before sacrificing at E16

KD endogenous Disc1

Disc1 shRNA

Hippocampus

n/d

Reduced BrdU positive cells, rescued by degradation of resistant β-catenin or GSK3-β inhibitor

n/d

DISC1 regulates neuronal progenitor proliferation by inhibiting GSK3-β
 
Lentivirus injected into the adult dentate gyrus,

BrdU 5 weeks later

KD endogenous Disc1

Disc1 shRNA

Hippocampus

n/d

Reduced BrdU positive cells,

rescued by GSK3-β inhibitor

Locomotor hyperactivity increased immobility in forced swim test
 
Clapcote

ENU mutagenesis, screening of DISC1 exon 2

Missense point mutations:

Q31L, L100P

n/a

Endogenous

Reduced brain volume

Reduced binding to PDE4B

Q31L: greater immobility in the forced swim test, reduced sociability, reduced sucrose consumption.

L100P: novelty-induced activity, deficits in PPI, latent inhibition, and working memory

A point mutation in Disc1 produced various abnormalities.

The two point mutants had different behavioral phenotypes (Q31L depression-like, L100P schizophrenia-like)

Koike

Kvajo

Spontaneous mutation in 129S6/SvEv, transferred to C57BL/6

Some Disc1 isoforms are missing

25 bp deletion in exon 6, results in premature stop codon in exon 7

Endogenous

Reduced prefrontal cortex volume

Altered organization of the dentate gyrus,

No difference in parvalbumin+ or calbindin+ staining in medial prefrontal cortex

Impaired working memory

Loss of some isoforms altered hippocampal morphology and memory performance. Note that all 129 substrains have the mentioned mutation which may affect the phenotypes of the models generated in them.

Hikida

Transgenic

Express C-terminally truncated human DISC1, dominant negative

Constitutive under CaMKII promoter

Olfactory bulbs, frontal cortex, hippocampus, basal ganglia postnatally

Enlarged lateral ventricles

Decreased parvalbumin+ immunoreactivity in the medial prefrontal cortex

Increased immobility in forced swim test, mild hyperactive in the open field,

PPI deficit

First DISC1 model based on a human mutation

Pletnikov

Transgenic

Express C-terminally truncated human DISC1, dominant negative

Bi-transgenic regulatory plasmid expresses tTA under CAMKII promoter

Hippocampus, cortex, striatum and olfactory bulb. Expression is highest at embryonic life, and decreases with age

Enlarged lateral ventricles

Decreased neurite outgrowth in primary neurons

Altered spatial memory in females; decreased social interaction and increased aggression in males

First inducible DISC1 model

Li

Transgenic

Express the C-terminus of DISC1, which competes on binding to NDEL1 and LIS1

Transgenic under CaMKII promoter, inducible by tamoxifen for <2 days

Cortex, hippocampus, striatum, cerebellum.

Activated at P7

n/d

Reduced hippocampal dendritic complexity

Impaired working memory, greater immobility in the forced swim test, reduced sociability

Short induction at P7 is sufficient to elicit significant abnormalities in adulthood

Shen

BAC (bacterial artificial chromosome) transgenic

Express C-terminally truncated mouse DISC1

Fused GFP in-frame to the end of exon 8

Endogenous

Smaller cortex, enlarged lateral ventricles, corpus callosum agenesis

Thinning of layers II/III due to reduced neuronal proliferation

Impaired latent inhibition, greater immobility in the forced swim test

Mouse transgene regulated by endogenous promoter



New models of DISC1 will advance our knowledge of the gene. One approach can include generating models with cell type-specific expression. For example, as DISC1 is proposed to be expressed in glial cells (58), mouse models with changes in expression of DISC1 in astrocytes or oligodendrocytes would provide new information on the function of DISC1 in those glial cells. Glia–neuron interaction is necessary for effective synaptic transmission and altered interaction might be associated with mental disorders (53, 59, 60). Abnormalities in glial expression of DISC1 might cause dysfunction in glial cellular operations and eventually disrupt glia–neuron interaction.

DISC1 is not the only susceptibility gene in schizophrenia in particular and for other major mental disorders. Distinct roles of NRG1, NRGIII, RGS4, DAO, AKT1, and PICK1 have been also demonstrated (6165) and corresponding animal models have been generated (6669). These mouse models may provide in vivo working models of how these genes interact (7073), how the common pathways are affected by a mutation in any of these genes, and what outcomes those interactions have at cellular, circuitry, systems, and behavioral levels. Evaluation of interactions between susceptibility genes may provide identification of pathways that may be targeted for preventive measures or treatment approaches.



References



1.

Kellendonk, C., Simpson, E. H., and Kandel, E. R. (2009) Modeling cognitive endophenotypes of schizophrenia in mice, Trends Neurosci 32, 347–358.PubMedCrossRef


2.

Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., and Steckler, T. (2009) Removing obstacles in neuroscience drug discovery: the future path for animal models, Neuropsychopharmacology 34, 74–89.PubMedCrossRef


3.

Laporte, J. L., Ren-Patterson, R. F., Murphy, D. L., and Kalueff, A. V. (2008) Refining psychiatric genetics: from ‘mouse psychiatry’ to understanding complex human disorders, Behav Pharmacol 19, 377–384.PubMedCrossRef


4.

Ressler, K. J., and Mayberg, H. S. (2007) Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic, Nat Neurosci 10, 1116–1124.PubMedCrossRef


5.

Jaaro-Peled, H., Yavuz, A., Pletnikov M. V., Sawa A. (2010) Building models for schizophrenia in rodents: structural and morphological aspects Schizophr Bull 36, 301–313.


6.

Gainetdinov, R. R., Mohn, A. R., and Caron, M. G. (2001) Genetic animal models: focus on schizophrenia, Trends Neurosci 24, 527–533.PubMedCrossRef


7.

O’Tuathaigh, C. M., Babovic, D., O’Meara, G., Clifford, J. J., Croke, D. T., and Waddington, J. L. (2007) Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour, Neurosci Biobehav Rev 31, 60–78.PubMedCrossRef


8.

Chen, J., Lipska, B. K., and Weinberger, D. R. (2006) Genetic mouse models of schizophrenia: from hypothesis-based to susceptibility gene-based models, Biol Psychiatry 59, 1180–1188.PubMedCrossRef


9.

Millar, J. K., Wilson-Annan, J. C., Anderson, S., Christie, S., Taylor, M. S., Semple, C. A., Devon, R. S., Clair, D. M., Muir, W. J., Blackwood, D. H., and Porteous, D. J. (2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia, Hum Mol Genet 9, 1415–1423.PubMedCrossRef


10.

Blackwood, D. H., Fordyce, A., Walker, M. T., St Clair, D. M., Porteous, D. J., and Muir, W. J. (2001) Schizophrenia and affective disorders – cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family, Am J Hum Genet 69, 428–433.PubMedCrossRef


11.

Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J., and Millar, J. K. (2008) The DISC locus in psychiatric illness, Mol Psychiatry 13, 36–64.PubMedCrossRef


12.

Davidzon, G., Greene, P., Mancuso, M., Klos, K. J., Ahlskog, J. E., Hirano, M., and DiMauro, S. (2006) Early-onset familial parkinsonism due to POLG mutations, Ann Neurol 59, 859–862.PubMedCrossRef


13.

Alzheimer’s Disease Collaborative Group (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families, Nat Genet 11, 219–222.


14.

Piscopo, P., Marcon, G., Piras, M. R., Crestini, A., Campeggi, L. M., Deiana, E., Cherchi, R., Tanda, F., Deplano, A., Vanacore, N., Tagliavini, F., Pocchiari, M., Giaccone, G., and Confaloni, A. (2008) A novel PSEN2 mutation associated with a peculiar phenotype, Neurology 70, 1549–1554.PubMedCrossRef


15.

Terzioglu, M., and Galter, D. (2008) Parkinson’s disease: genetic versus toxin-induced rodent models, FEBS J 275, 1384–1391.PubMedCrossRef


16.

Morris, J. A., Kandpal, G., Ma, L., and Austin, C. P. (2003) DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation, Hum Mol Genet 12, 1591–1608.PubMedCrossRef
< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 10, 2016 | Posted by in INTERNAL MEDICINE | Comments Off on DISC1 Mouse Models

Full access? Get Clinical Tree

Get Clinical Tree app for offline access